Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Arthritis and Disability: Biracial Cohort Study of Knee and Hip Osteoarthritis, Potential Extramural Project (PEP) 2007-R-06 and Evaluating Sustainable Delivery Systems for Arthritis Intervention Programs, PEP 2007-R-08, 17554-17555 [E7-6582]

Download as PDF 17554 Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices hereditary genetic risk for ovarian cancer that the currently available screening modalities of CA 125 and transvaginal ultrasound are recommended. Statements from the scientific and medical community regarding recommendations for ovarian cancer screening play only a partial role in a woman’s decision to undergo screening exams. Numerous psychological and sociological factors can affect this decision as well, including a woman’s knowledge, attitudes, beliefs, and experiences. For instance, a woman’s experience of cancer within her family or experience with a friend who has had cancer may influence a woman’s screening decisions. The literature also notes that women with a family history of ovarian cancer report increased worry and high levels of perceived risk. A positive association has also been shown between screening behavior and family history. Recent studies indicate, however, that screening is not occurring in proportion to women’s levels of risk. These findings underscore the need for a better understanding of how perceived risk of ovarian cancer may influence worry about cancer and ultimately screening behavior. To address these issues, the Division of Cancer Prevention and Control (DCPC), at the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, is conducting a study to examine the effects of family history of cancer, knowledge about ovarian cancer, worry and/or anxiety, and perceived risk of cancer on the likelihood of a woman undergoing screening for ovarian cancer. By also examining other psycho-social factors such as a woman’s closeness to a relative or friend with cancer, coping style, cancer worry, use of other cancer screening tests, social support, and provider’s recommendations, the study will elucidate the causal pathway leading from actual risk (as measured by family history) through perceived risk to intent to undergo screening and actual screening behavior. The proposed study will consist of two tasks. In Task 1, a baseline survey will be administered through a computer-assisted telephone interview (CATI) program. Initially, an estimated 32,000 women will be screened to determine eligibility, and then approximately 2000 women will be asked a series of questions over a 35minute time period. Questions will cover key variables related to ovarian cancer screening including coping, anxiety, perceived risk, worry, personal cancer history, family cancer history, closeness with family or friends who have had cancer, screening behavior, and knowledge of ovarian cancer. In Task 2, a follow-up questionnaire will be administered, also using a CATI program, to approximately 1600 of the women included in the baseline questionnaire. Each of the women will be contacted one year after they complete the baseline survey. The researchers anticipate a 15 percent attrition of the sample between baseline and follow-up. In the follow-up, women will be asked a series of questions over a 15-minute time period. The purpose of this data collection effort is to determine if risk perception has changed and to ask about screening for ovarian cancer, since the baseline questionnaire was administered. All data will be collected over a threeyear time period. The total estimated annualized burden hours are 1,411. There are no costs to the respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS No. of respondents Group Type of respondents Eligibility Screener .......................................... Baseline Survey .............................................. Women 30 and older ..................................... Women 30 and older (high, elevated or average risk of ovarian cancer). Women who completed the baseline survey Follow-Up Survey ............................................ DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P sroberts on PROD1PC70 with NOTICES Dated: April 3, 2007. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–6583 Filed 4–6–07; 8:45 am] Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Arthritis and Disability: Biracial Cohort Study of Knee and Hip Osteoarthritis, Potential Extramural Project (PEP) 2007–R–06 and Evaluating Sustainable Delivery Systems for Arthritis Intervention Programs, PEP 2007–R–08 Centers for Disease Control and Prevention In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned SEP. Time and Date: 12 p.m.–4 p.m., May 14, 2007 (Closed). Place: Teleconference. VerDate Aug<31>2005 18:21 Apr 06, 2007 Jkt 211001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 No. of responses per respondent Avg. burden per response (in hours) 10,667 667 1 1 5/60 35/60 533 1 15/60 Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Arthritis and Disability: Biracial Cohort Study of Knee and Hip Osteoarthritis,’’ Potential Extramural Project (PEP) 2007–R–06 and ‘‘Evaluating Sustainable Delivery Systems for Arthritis Intervention Programs,’’ PEP 2007– R–08. For Further Information Contact: Juliana Cyril, M.P.H., Ph.D., CDC, 1600 Clifton Road NE, Mailstop D–72, Atlanta, GA 30333, Telephone (404) 639–4639. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\09APN1.SGM 09APN1 Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices Dated: April 2, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–6582 Filed 4–6–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 2, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–6588 Filed 4–6–07; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention 17555 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 2, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–6589 Filed 4–6–07; 8:45 am] BILLING CODE 4163–18–P Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Pre-Knowledge of Early Hearing Detection and Intervention Program Process and Its Effect on Maternal Stress and Compliance With Follow-Up, Potential Extramural Project (PEP) 2007–R–07 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12 p.m.–4 p.m., May 16, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of PEP 2007–R–07, ‘‘PreKnowledge of Early Hearing Detection and Intervention Program Process and Its Effect on Maternal Stress and Compliance with Follow-Up.’’ For Further Information Contact: Juliana Cyril, M.P.H., Ph.D., Associate Director for Policy and Peer Review, CDC, 1600 Clinton Road, NE., Mailstop D72, Atlanta, GA 30333, telephone 404–639–4639. The Director, Management Analysis and Services Office, has been delegated the DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Epidemiological Studies of Epilepsy, Potential Extramural Project (PEP) 2007–R–05 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned SEP. Time and Date: 12 p.m.–4 p.m., May 10, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of scientific merit of applications for ‘‘Epidemiological Studies of Epilepsy,’’ PEP 2007–R–05. For Further Information Contact: Juliana Cyril, M.P.H., Ph.D., Associate Director for Policy and Peer Review, CDC, 1600 Clifton Road, NE., Mailstop D–72, Atlanta, GA 30333, Telephone (404) 639–3098. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: NIOSH Education and Research Center, Program Announcement Number (PAR) 06–485 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Meeting of the aforementioned Special Emphasis Panel: Time and Date: 10 a.m.–1 p.m., April 24, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Purpose: The work groups which were convened at specific sites listed below advised and made recommendations to the Disease, Disability, and Injury Prevention and Control SEP: NIOSH Education and Research Center, PAR 06–485. Specifically, the SEP makes recommendations regarding policies, strategies, and funding. TIMES, DATES, AND PLACES OF THE WORK GROUP MEETINGS November 13, 2006 (Closed) ................ 8 a.m.–5 p.m. .......... November 28, 2006 (Closed) ................ 8 8 8 8 8 sroberts on PROD1PC70 with NOTICES 8 a.m.–5 p.m. .......... December 11, 2006 (Closed) ................ December 14, 2006 (Closed) ................ January 9, 2007 (Closed) ...................... January 16, 2007 (Closed) .................... February 13, 2007 (Closed) .................. a.m.–5 a.m.–5 a.m.–5 a.m.–5 a.m.–5 p.m. p.m. p.m. p.m. p.m. .......... .......... .......... .......... .......... Matters to be Discussed: The SEP meeting will include the review, discussion, and evaluation of research grant applications in response to ‘‘NIOSH Education and Research Center,’’ PAR 06–485. VerDate Aug<31>2005 18:21 Apr 06, 2007 Jkt 211001 Women’s Faculty Club on the University of California Berkeley campus 510– 642–4175. University of Alabama at Birmingham, Administration Building Penthouse, 701 20th Street South, 14th floor, Conference Room 1, 205–934–0771. Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD 21205. College of Public Health 13201 Bruce B. Downs Blvd Tampa, FL 33612. Fitzsimons Campus, Nighthorse Campbell Building. Room 304 Denver, CO. Coffman Memorial Union 300 Washington Ave. SE Minneapolis, MN 55455. University Park Marriott 480 Wakara Way Salt Lake City, UT 84108 801–584– 3312. For Further Information Contact: Dr. Charles N. Rafferty, Ph.D., B.S., Scientific Review Administrator, 1600 Clifton Road NE, MS E74, Atlanta, GA, 30333, telephone 404.498.2582. PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 72, Number 67 (Monday, April 9, 2007)]
[Notices]
[Pages 17554-17555]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6582]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Arthritis and Disability: Biracial Cohort Study 
of Knee and Hip Osteoarthritis, Potential Extramural Project (PEP) 
2007-R-06 and Evaluating Sustainable Delivery Systems for Arthritis 
Intervention Programs, PEP 2007-R-08

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
SEP.

    Time and Date: 12 p.m.-4 p.m., May 14, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Arthritis and Disability: Biracial 
Cohort Study of Knee and Hip Osteoarthritis,'' Potential Extramural 
Project (PEP) 2007-R-06 and ``Evaluating Sustainable Delivery 
Systems for Arthritis Intervention Programs,'' PEP 2007- R-08.
    For Further Information Contact: Juliana Cyril, M.P.H., Ph.D., 
CDC, 1600 Clifton Road NE, Mailstop D-72, Atlanta, GA 30333, 
Telephone (404) 639-4639.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.


[[Page 17555]]


    Dated: April 2, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E7-6582 Filed 4-6-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.